medigraphic.com

2014, Number 5

<< Back Next >>

Rev Med Inst Mex Seguro Soc 2014; 52 (5)

Obesity and components of metabolic syndrome in Mexican women survivors of cancer

Ortiz-Mendoza CM, de la Fuente-Vera TA

Language: Spanish
References: 21
Page: 588-593
PDF size: 187.54 Kb.


ABSTRACT

Background: Some studies suggest that obesity and metabolic syndrome are frequent in cancer survivors. In our country, there is a lack of documentation with regards to this problem in women. Therefore, our aim is to establish the prevalence of obesity and metabolic syndrome components in surviving Mexican women.
Methods: We elected women who received treatment for cancer with a surviving ≥ 24 months. The data evaluated were demography, clinical anthropometry, blood pressure measurement, kind of cancer, surviving time, and comorbidities, as well as glucose, cholesterol, and triglyceride levels.
Results: We studied 107 women. Their average age was 60 ± 10 years, with a surviving time of 77 ± 43 months, and a body mass index of 31 ± 6 kg/m2. Their mean glucose level was 120 ± 58 mg/dL, cholesterol 228 ± 43 mg/dL, and triglycerides 207 ± 120 mg/dL. There were 55 (51 %) with glucose › 99 mg/dL, 85 (79 %) with cholesterol › 199 mg/dL, and 67 (63 %) with triglycerides › 149 mg/dL. Obesity (body mass index ≥ 30 kg/m2) occurred in 49 (46 %) and metabolic syndrome in 27 (26 %).
Conclusion: Due to a high prevalence of obesity, metabolic syndrome components were frequent.


REFERENCES

  1. Mosher CE, Sloane R, Morey MC, Snyder DC, Cohen HJ, Miller PE, et al. Association between lifestyle factors and quality of life among older long-term breast, prostate, and colorectal cancer survivors. Cancer. 2009;115(17):4001-9. Texto libre en http:// www.ncbi.nlm.nih.gov/pmc/articles/PMC2743037/

  2. Lajous M, Mozaffarian D, Mozaffarian R, Schrag D, Adami HO. Lifestyle prescriptions for cancer survivors and their communities. J Intern Med. 2011;269(1):88- 93. doi: 10.1111/j.1365-2796.2010.02273.x.

  3. Edgington A, Morgan MA. Looking beyond recurrence: comorbidities in cancer survivors. Clin J Oncol Nurs. 2011;15(1):E3-12. doi: 10.1188/11.CJON.E3-E12.

  4. Ganz PA. Survivorship: adult cancer survivors. Prim Care. 2009;36(4):721-41. doi: 10.1016/j. pop.2009.08.001.

  5. Pais R, Silaghi H, Silaghi AC, Rusu ML, Dumitrascu DL. Metabolic syndrome and risk of subsequent colorectal cancer. World J Gastroenterol. 2009;15(41):5141-8.

  6. Pi-Sunyer X. The medical risks of obesity. Postgrad Med. 2009;121(6):21-33.

  7. De Haas EC, Oosting SF, Lefrandt JD, Wolffenbuttel BH, Sleijfer DT, Gietema JA. The metabolic syndrome in cancer survivors. Lancet Oncol. 2010;11(2):193- 203. doi: 10.1016/S1470-2045(09)70287-6.

  8. Jung HS, Myung SK, Kim BS, Seo HG. Metabolic syndrome in adult cancer survivors: a meta-analysis. Diabetes Res Clin Pract. 2012;95(2):275-82.

  9. Barquera S, Campos-Nonato I, Hernández-Barrera L, Flores M, Durazo-Arvizu R, Kanter R, et al. Obesity and central adiposity in Mexican adults: results from the Mexican National Health and Nutrition Survey 2006. Salud Publica Mex. 2009;51(Suppl 4):S595-S603.

  10. Reeves GK, Pirie K, Beral V, Green J, Spencer E, Bull D; Million Women Study Collaboration. Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ. 2007;335(7630):1134. Texto libre en http://www. ncbi.nlm.nih.gov/pmc/articles/PMC2099519/

  11. Castillejos-Molina R, Rodríguez-Covarrubias F, Sotomayor M, Gómez-Alvarado MO, Villalobos-Gollás M, Gabilondo F, et al. Impact of metabolic syndrome on biochemical recurrence of prostate cancer after radical prostatectomy. Urol Int. 2011;87(3):270-5.

  12. Kuri-Morales P, Emberson J, Alegre-Díaz J, Tapia- Conyer R, Collins R, Peto R, et al. The prevalence of chronic diseases and major disease risk factors at different ages among 150,000 men and women living in Mexico City: cross-sectional analyses of a prospective study. BMC Public Health. 2009;9:9. doi: 10.1186/1471-2458-9-9. Texto libre en http:// www.biomedcentral.com/1471-2458/9/9

  13. Rojas-Martínez R, Aguilar-Salinas CA, Jiménez- Corona A, Gómez-Pérez FJ, Barquera S, Lazcano- Ponce E. Prevalence of obesity and metabolic syndrome components in Mexican adults without type 2 diabetes or hypertension. Salud Publica Mex. 2012;54(1):7-12.

  14. Nguyen NT, Nguyen XM, Lane J, Wang P. Relationship between obesity and diabetes in a US adult population: fi ndings from the National Health and Nutrition Examination Survey, 1999-2006. Obes Surg. 2011;21(3):351-5. Texto libre en http://www. ncbi.nlm.nih.gov/pmc/articles/PMC3040808/

  15. Rojas R, Aguilar-Salinas CA, Jiménez-Corona A, Shama-Levy T, Rauda J, Ávila-Burgos L, et al. Metabolic syndrome in Mexican adults. Results from the National Health and Nutrition Survey 2006. Salud Publica Mex. 2010;52 (Suppl 1):S11-S18.

  16. Von Gruenigen VE, Waggoner SE, Frasure HE, Kavanagh MB, Janata JW, Rose PG, et al. Lifestyle challenges in endometrial cancer survivorship. Obstet Gynecol. 2011;117(1):93-100. doi: 10.1097/ AOG.0b013e31820205b3.

  17. Rosato V, Zucchetto A, Bosetti C, Dal Maso L, Montella M, Pelucchi C, et al. Metabolic syndrome and endometrial cancer risk. Ann Oncol. 2011;22(4):884-9.

  18. Méndez-Durán A, Rivera-Ayala LL, Bonfi l-Rodríguez MI, Navarrete-Huerta F, Lizcano-Esperón F, Guerrero-Aguirre J. Perfi l metabólico y renal de la población que acude a consulta médica en un segundo nivel de atención. Rev Esp Méd Quir. 2011;16(2):104-9.

  19. Aguilar-Salinas CA, Gómez-Pérez FJ, Rull J, Villalpando S, Barquera S, Rojas R. Prevalence of dyslipidemias in the Mexican National Health and Nutrition Survey 2006. Salud Publica Mex. 2010;52 (Suppl 1):S44-S53.

  20. Guerrero-Romero F, Rodríguez-Morán M, Pérez- Fuentes R, Sánchez-Guillén MC, González-Ortiz M, Martínez-Abundis E, et al. Prediabetes and its relationship with obesity in Mexican adults: The Mexican Diabetes Prevention (Mex Diab) Study. Metab Syndr Relat Disord. 2008;6(1):15-23. doi: 10.1089/ met.2007.0020.

  21. Thomson CA, Thompson PA, Wright-Bea J, Nardi E, Frey GR, Stopeck A. Metabolic syndrome and elevated C-reactive protein in breast cancer survivors on adjuvant hormone therapy. J Womens Health (Larchmt). 2009;18(12):2041-7. Texto libre en http:// www.ncbi.nlm.nih.gov/pmc/articles/PMC2828195/




2020     |     www.medigraphic.com